Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01HBS
|
||||
Former ID |
DNC009009
|
||||
Drug Name |
Cyclohexylcarbamic acidbiphenyl-3-yl ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529498] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H21NO2
|
||||
Canonical SMILES |
C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
|
||||
InChI |
1S/C19H21NO2/c21-19(20-17-11-5-2-6-12-17)22-18-13-7-10-16(14-18)15-8-3-1-4-9-15/h1,3-4,7-10,13-14,17H,2,5-6,11-12H2,(H,20,21)
|
||||
InChIKey |
KGKDDSYRBQOMLE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.